Latest News and Press Releases
Want to stay updated on the latest news?
-
Revenue of $7.4 Billion Decreased 0.1% Reported; Increased 6.8% Organic GAAP Diluted EPS of $0.79; Non-GAAP Diluted EPS of $1.17 Company Updates FY19 Revenue and EPS Guidance DUBLIN -...
-
Boca Raton, Florida, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Thousands of participants will gather to further their knowledge and understanding of preventive, personalized medicine at the three-day...
-
DUBLIN - August 9, 2018 - Medtronic today announced the official U.S. launch of the Medtronic Inner CircleSM patient engagement program, which uses gamification - the application of game design...
-
BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a...
-
First-Year Results Demonstrate a 27 Percent Decline in Rate of Preventable Hospital Admissions for Medtronic Insulin Pump Users Compared to Patients on Multiple Daily Injections of Insulin ...
-
GREENVILLE, Wis. and ROCHESTER, N.Y., July 10, 2018 (GLOBE NEWSWIRE) -- School Specialty, Inc. (OTCQB:SCOO) and Mobilize Rescue Systems announced today a partnership to place life-saving medical...
-
Moves into Phase Two - Semantic Segmentation Machine Learning System Development SAN DIEGO, CA, July 10, 2018 (GLOBE NEWSWIRE) -- Gopher Protocol Inc. (OTCQB:GOPH) ("Gopher"), a company...
-
Innovation Pharmaceuticals Announces Database Lock for Phase 2b Trial of Oral Prurisol for Psoriasis
BEVERLY, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces database lock for its Phase 2b...
-
BEVERLY, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that it has entered into...
-
DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based...